Drugs Made In America Acquisition II Corp Right
DMIIR
62 hedge funds and large institutions have $3.31M invested in Drugs Made In America Acquisition II Corp Right in 2026 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 0 closing their positions.
9% more funds holding
Funds holding: 57 → 62 (+5)
2% more capital invested
Capital invested by funds: $3.25M → $3.31M (+$55.1K)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAL
TIG Advisors LLC
New York
|
+$42.8K |
| 2 |
SIA
SkyView Investment Advisors
Shrewsbury,
New Jersey
|
+$21.4K |
| 3 |
SAMU
SONA Asset Management (US)
New York
|
+$21.4K |
| 4 |
KC
Kepos Capital
New York
|
+$16.1K |
| 5 |
CS
Clear Street
New York
|
+$13.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$33.5K |
| 2 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$2.3K |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$1.17K |
| 4 |
HCM
Heights Capital Management
San Francisco,
California
|
-$964 |
| 5 |
KC
Kryger Capital
London,
United Kingdom
|
-$714 |
DMIIR Hedge Fund Activity: Q2 2026 in Review
62 of the 8,344 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp Right (DMIIR) for Q2 2026, worth a combined $3.31M — up 1.7% from $3.25M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new DMIIR positions and 0 closed out — a net gain of 5 holders — while 6 added to existing stakes and 8 trimmed.
The largest buyer was TIG Advisors LLC, opening a new position worth an estimated $42.8K. The largest seller was Hudson Bay Capital Management, cutting an estimated $33.5K.
- 62 institutional investors held Drugs Made In America Acquisition II Corp Right (DMIIR) as of Q2 2026, up from 57 in Q1 2026.
- Funds reported $3.31M of Drugs Made In America Acquisition II Corp Right stock for Q2 2026, up 1.7% quarter-over-quarter.
- 5 funds opened new Drugs Made In America Acquisition II Corp Right positions in Q2 2026 and 0 closed out, a net change of +5 holders.
- The largest Drugs Made In America Acquisition II Corp Right buyer in Q2 2026 was TIG Advisors LLC, an estimated $42.8K added.
- The largest Drugs Made In America Acquisition II Corp Right seller in Q2 2026 was Hudson Bay Capital Management, an estimated $33.5K sold.
Based on aggregated 13F filings for Q2 2026.